UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 14, 2015

 

Patriot Scientific Corporation

(Exact name of registrant as specified in its charter)

 

Delaware   000-22182   84-1070278
(State of other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)
         

 

701 Palomar Airport Road, Suite 170, Carlsbad, California 92011
(Address of Principal Executive Offices)
         
Registrant’s telephone number, including area code: (760) 547-2700
 
Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

o            Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

Item 8.01       Other Events.

 

On April 14, 2015, Patriot Scientific Corporation (the “Company”) issued a press release that provided updated information regarding the filing of its quarterly report on Form 10-Q and the appointment of replacement legal counsel in its current cases before the United States District Court for the Northern District of California in continuing to protect its intellectual property rights. A copy of the press release is attached hereto as Exhibit 99.1.

 

 

Item 9.01       Financial Statements and Exhibits

 

(d)          Exhibits.  The following material is filed as an exhibit to this Current Report on Form 8-K:

  

Exhibit

Number

 

99.1                      Press Release issued April 14, 2015

 

2
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Patriot Scientific Corporation
   
   
   
Date: April 20, 2015 By: /s/ Clifford L. Flowers
  Clifford L. Flowers
  Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

3
 

 

EXHIBIT INDEX

 

 

 

Exhibit
Number		 Description
   
99.1    Press Release issued April 14, 2015

 

 

 

 

 

 

 

 

 

 

 

4



Exhibit 99.1

Contact:

Patriot Investor Relations

ir@ptsc.com

760-547-2700 x-102

 

 

Patriot Scientific Corporation Files Quarterly Report and Provides Legal Update

 

CARLSBAD, Calif., April 14, 2015--(PR Newswire)-Patriot Scientific Corporation (OTCQB: PTSC) today announced it has filed its Report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended February 28, 2015. The Report can be found on the SEC’s website at http://www.sec.gov/cgi-bin/browse-edgar.

 

As disclosed in our quarterly filing, Agility IP Law, LLP, patent litigation counsel for the assertion of the Moore Microprocessor Patent (MMP) Portfolio™, has advised us that their firm is in the process of dissolution. As a result, Phoenix Digital Solutions, the joint-venture entity representing our interests in the MMP Portfolio, has hired the firm of Nelson Bumgardner, P.C. to take over as lead trial counsel in the current cases before the United States District Court for the Northern District of California in continuing to protect our intellectual property rights. “We are very pleased to represent PDS in the current actions and look forward to bringing about successful resolutions for all the MMP Portfolio’s stakeholders,” stated Barry Bumgardner.

 

As a reminder, the Annual Meeting of Stockholders of Patriot Scientific Corporation is scheduled for April 30, 2015, at 10:00 AM Pacific Time. The meeting will be conducted in a virtual format, with participation available via the Internet. Instructions for attending the meeting have been included in Patriot’s proxy materials distributed to all stockholders of record as of the close of business on March 6, 2015.

 

A unique control number provided in the proxy materials will allow stockholders access to the virtual meeting on April 30, 2015. We encourage stockholders to visit www.proxyvote.com where shares can be voted and questions can be submitted via the Stockholder Forum.

 

We look forward to your participation.

 

 

About Patriot Scientific Corporation

Headquartered in Carlsbad, California, Patriot Scientific Corporation is the co-owner of the Moore Microprocessor Patent Portfolio™. For more information on PTSC, visit www.ptsc.com.

 

About the MMP Portfolio™

The MMP Portfolio includes US patents as well as their European and Japanese counterparts, which cover techniques that enable higher performance and lower cost designs essential to consumer and commercial digital systems ranging from PCs, cell phones and portable music players to communications infrastructure, medical equipment and automobiles.

 

Safe Harbor Statement: Statements herein which are not purely historical, including statements regarding Patriot Scientific Corporation's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risks and uncertainties relating to the future of our MMP joint-venture and the licensing and litigation strategies employed by the joint venture.  It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, and seasonality.  Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the quarterly report on Form 10-Q for the period ended February 28, 2015, and the annual report on Form 10-K for the year ended May 31, 2014. The company cautions investors not to place undue reliance on the forward-looking statements contained herein. Patriot Scientific Corporation disclaims any obligation, and does not undertake to update or revise any forward-looking statements made herein.